Insider · CIK 0001409601

Clancy Paul J

Reports to the SEC for 7 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001409601

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	INCYINCYTE CORPA Award	Director	AAward	+203 sh	$121.35	+$24.6K	25,838
2026-06-30	INCYINCYTE CORPA Award	Director	AAward	+252 sh	$113.36	+$28.6K	25,635
2026-06-17	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.3K sh	—	—	17,340
2026-06-08	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+6,111 sh	—	—	6,111
2026-06-08	INCYINCYTE CORPA Award	Director	AAward	+1,642 sh	—	—	25,383
2026-05-19	INCYINCYTE CORPS Sale	Director	SSale	−15K sh	$94.93	−$1.42M	23,741
2026-05-19	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2026-05-19	INCYINCYTE CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$84.53	+$1.27M	38,741
2026-03-31	INCYINCYTE CORPA Award	Director	AAward	+265 sh	$94.12	+$24.9K	23,741
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−20.6K sh	—	—	5,398
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−5,398 sh	—	—	0
2025-12-31	INCYINCYTE CORPA Award	Director	AAward	+241 sh	$98.77	+$23.8K	23,476
2025-09-30	INCYINCYTE CORPA Award	Director	AAward	+285 sh	$84.81	+$24.2K	23,235
2025-06-30	INCYINCYTE CORPA Award	Director	AAward	+361 sh	$68.10	+$24.6K	22,950
2025-06-12	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	19,959
2025-06-12	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,398 sh	—	—	26,038
2025-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2025-06-10	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+9,216 sh	—	—	9,216
2025-06-10	INCYINCYTE CORPA Award	Director	AAward	+2,518 sh	—	—	22,589
2025-03-31	INCYINCYTE CORPA Award	Director	AAward	+358 sh	$60.55	+$21.7K	20,071
2024-12-31	INCYINCYTE CORPA Award	Director	AAward	+331 sh	$69.07	+$22.9K	19,713
2024-09-30	INCYINCYTE CORPA Award	Director	AAward	+368 sh	$66.10	+$24.3K	19,382
2024-06-28	INCYINCYTE CORPA Award	Director	AAward	+399 sh	$60.62	+$24.2K	19,014
2024-06-14	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-06-13	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,939 sh	—	—	20,640
2024-06-13	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,444 sh	—	—	20,145
2024-06-12	INCYINCYTE CORPA Award	Director	AAward	+2,830 sh	—	—	18,615
2024-06-12	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,517
2024-03-28	INCYINCYTE CORPA Award	Director	AAward	+403 sh	$56.97	+$23K	15,785
2023-12-29	INCYINCYTE CORPA Award	Director	AAward	+412 sh	$62.79	+$25.9K	15,382
2023-09-29	INCYINCYTE CORPA Award	Director	AAward	+379 sh	$57.77	+$21.9K	14,970
2023-06-30	INCYINCYTE CORPA Award	Director	AAward	+380 sh	$62.25	+$23.7K	14,591
2023-06-14	INCYINCYTE CORPA Award	Director	AAward	+2,505 sh	—	—	14,211
2023-06-14	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,294
2023-06-12	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,200
2023-06-08	EXASEXACT SCIENCES CORPA Award	Director	AAward	+3,599 sh	—	—	14,701
2023-03-31	INCYINCYTE CORPA Award	Director	AAward	+318 sh	$72.27	+$23K	11,706
2022-12-30	INCYINCYTE CORPA Award	Director	AAward	+294 sh	$80.32	+$23.6K	11,388
2022-09-30	INCYINCYTE CORPA Award	Director	AAward	+339 sh	$66.64	+$22.6K	11,094
2022-06-30	INCYINCYTE CORPA Award	Director	AAward	+321 sh	$75.97	+$24.4K	10,755
2022-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+29.3K sh	—	—	29,307
2022-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitA Award	Director	AAward	+4,975 sh	—	—	4,975
2022-06-15	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,200
2022-06-15	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,124 sh	—	—	9,124
2022-06-15	INCYINCYTE CORPA Award	Director	AAward	+2,144 sh	—	—	10,434
2022-06-09	EXASEXACT SCIENCES CORPA Award	Director	AAward	+5,606 sh	—	—	11,102
2022-05-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,585 sh	—	—	6,549
2022-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitM Exercise/Conversion	Director	MExercise/Conversion	−1,585 sh	—	—	0
2022-03-31	INCYINCYTE CORPA Award	Director	AAward	+326 sh	$79.42	+$25.9K	8,290
2021-12-31	INCYINCYTE CORPA Award	Director	AAward	+343 sh	$73.40	+$25.2K	7,964

Recent filings

Accepted (ET)
Oct 24
Clancy Paul J0001409601-26-000015
SEC(opens sec.gov)
Jul 24
Clancy Paul J0001409601-26-000011
SEC(opens sec.gov)
Jun 184
Clancy Paul J0001409601-26-000010
SEC(opens sec.gov)
Jun 104
Clancy Paul J0001409601-26-000008
SEC(opens sec.gov)
May 214
Clancy Paul J0001409601-26-000006
SEC(opens sec.gov)
Apr 24
Clancy Paul J0001409601-26-000004
SEC(opens sec.gov)
Mar 234
Clancy Paul J0001193125-26-118743
SEC(opens sec.gov)
Jan 54
Clancy Paul J0001409601-26-000002
SEC(opens sec.gov)
Oct 24
Clancy Paul J0001409601-25-000004
SEC(opens sec.gov)
Jul 24
Clancy Paul J0000879169-25-000070
SEC(opens sec.gov)
Jun 164
Clancy Paul J0002036042-25-000028
SEC(opens sec.gov)
Jun 164
Clancy Paul J0000950170-25-086889
SEC(opens sec.gov)
Jun 124
Clancy Paul J0001415889-25-016968
SEC(opens sec.gov)
Jun 124
Clancy Paul J0001628280-25-031006
SEC(opens sec.gov)
Apr 24
Clancy Paul J0001628280-25-016172
SEC(opens sec.gov)

Companies

Address

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE, 19803